The partners will use Cellino's autonomous biomanufacturing tech to produce high-quality autologous iPSCs for Karis' cardiovascular therapy.

Osteochondral autologous transplantation may be an effective treatment option for adolescent athletes with capitellar osteochondritis dissecans, according to results presented here.“This study has ...

Roche has secured approval from the European Commission (EC) for Columvi (glofitamab) plus gemcitabine and oxaliplatin (GemOx ...

BASEL, Switzerland I April 14, 2025 I Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Columvi® (glofitamab) in ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

In this interview, Chiara Nozzoli, speaks on her career journey and her work in haematopoietic stem cell transplantation, ...

The Lokmanya Tilak Municipal Medical College and General Hospital (LTMGH) at Sion completed 104 bone marrow transplants (BMT) ...

If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to ...

When Dr. Filippo Milano left his home in Italy to study medicine in Seattle in 2008, it was supposed to be for six months, just long enough to learn how to do bone marrow transplant. Instead, he ...

High-dose chemotherapy and HSCT can provide long-term benefits in patients with MCL, a retrospective study suggests.

The Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), since the experiments in rodents in the 50’s, has become a complex procedure increasingly used for the treatment of an increasing number ...

Kyverna Therapeutics, Inc.’s KYTX share price has dipped by 13.16%, which has investors questioning if this is right time to buy.